Literature DB >> 1436094

Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.

D Arnold1, J Driscoll, M Androlewicz, E Hughes, P Cresswell, T Spies.   

Abstract

Antigen processing provides major histocompatibility complex (MHC) class I molecules with short peptides, which they selectively bind and present to cytotoxic T lymphocytes. The proteolytic system generating these peptides in the cytosol is unidentified, but their delivery into the endoplasmic reticulum is mediated by the TAP1-TAP2 transporter encoded in the MHC class II region. Closely linked to TAP1 and TAP2 are genes for the LMP2 and LMP7 proteins, which resemble components of proteasomes, proteolytic complexes known to degrade cytosolic proteins. This association has led to the common assumption that proteasomes function in this immunological pathway (discussed in ref. 15). We now show that the expression of stably assembled class I molecules and apparently normal peptide processing can be completely restored in the absence of LMP2 and LMP7 in the human lymphoblastoid cell line mutant 721.174 (refs 16, 17). The identity of LMP7 is directly confirmed by reconstitution of a proteasomal subunit after gene transfer. These results therefore dispute the hypothetical involvement of proteasomes in antigen processing, although a more subtle effect of LMP2 and LMP7 cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436094     DOI: 10.1038/360171a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  44 in total

1.  The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome.

Authors:  M Groettrup; S Standera; R Stohwasser; P M Kloetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Proteasomes: multicatalytic proteinase complexes.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

3.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.

Authors:  R A Colbert; S L Rowland-Jones; A J McMichael; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

4.  Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

Authors:  S A Thomson; R Khanna; J Gardner; S R Burrows; B Coupar; D J Moss; A Suhrbier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

5.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

Authors:  R A Henderson; A L Cox; K Sakaguchi; E Appella; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 6.  [Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis].

Authors:  W Hilt; D H Wolf
Journal:  Naturwissenschaften       Date:  1995-06

Review 7.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 8.  Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

Authors:  N P Restifo; Y Kawakami; F Marincola; P Shamamian; A Taggarse; F Esquivel; S A Rosenberg
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10

9.  Polymorphic peptide transporters in MHC class I monomorphic Syrian hamster.

Authors:  M Lobigs; H S Rothenfluh; R V Blanden; A Müllbacher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Genomic organization and tissue expression of the mouse proteasome gene Lmp-7.

Authors:  E Zanelli; P Zhou; H Cao; M K Smart; C S David
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.